<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33403218</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2328-8957</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Open forum infectious diseases</Title><ISOAbbreviation>Open Forum Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Postacute COVID-19: An Overview and Approach to Classification.</ArticleTitle><Pagination><StartPage>ofaa509</StartPage><MedlinePgn>ofaa509</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ofaa509</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ofid/ofaa509</ELocationID><Abstract><AbstractText>As the coronavirus disease 2019 (COVID-19) pandemic has progressed, a large volume of literature has developed delineating the clinical manifestations of acute infection. Recent reports have also started to describe persistent symptoms extending beyond the period of initial illness or hospitalization. Anecdotes of different signs and symptoms occurring after acute infection have also arisen in the lay press. Here we describe the current existing medical literature on the emerging concept of postacute COVID-19 and suggest an approach to classifying different manifestations of the syndrome. We also review long-term clinical manifestations observed in patients who recovered from infection due to other epidemic coronaviruses and briefly discuss potential mechanisms driving the phenomenon of postacute COVID-19.</AbstractText><CopyrightInformation>Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amenta</LastName><ForeName>Eva M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>General Internal Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spallone</LastName><ForeName>Amy</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7513-6522</Identifier><AffiliationInfo><Affiliation>Infectious Diseases Section, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Barradas</LastName><ForeName>Maria C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Infectious Diseases Section, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Sahly</LastName><ForeName>Hana M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Infectious Diseases Section, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atmar</LastName><ForeName>Robert L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Infectious Diseases Section, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kulkarni</LastName><ForeName>Prathit A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Infectious Diseases Section, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 AI055413</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Open Forum Infect Dis</MedlineTA><NlmUniqueID>101637045</NlmUniqueID><ISSNLinking>2328-8957</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">definition</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">postacute</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>6</Day><Hour>5</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33403218</ArticleId><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="doi">10.1093/ofid/ofaa509</ArticleId><ArticleId IdType="pii">ofaa509</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
National Institutes of Health. COVID-19 treatment guidelines Updated 17 July 2020.  Available at: https://www.covid19treatmentguidelines.nih.gov/overview/management-of-covid-19/. Accessed 7 October 2020.</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ &#xa0;2020; 370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention. Duration of isolation and precautions for adults with COVID-19. Updated 16 August 2020.  Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html. Accessed 31 August 2020.</Citation></Reference><Reference><Citation>Xiao AT, Tong YX, Zhang S. Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients. Clin Infect Dis &#xa0;2020; 71:2249&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188124</ArticleId><ArticleId IdType="pubmed">32306036</ArticleId></ArticleIdList></Reference><Reference><Citation>Noh JY, Yoon JG, Seong H, et al. &#xa0;Asymptomatic infection and atypical manifestations of COVID-19: comparison of viral shedding duration. J Infect. In press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240269</ArticleId><ArticleId IdType="pubmed">32445728</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA &#xa0;2020; 324:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. &#xa0;Post-discharge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation [published online ahead of print July 30, 2020]. J Medical Virol &#xa0;2020. doi:10.1002/jmv.26368</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. &#xa0;Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19 [published online ahead of print July 30, 2020]. J Infect &#xa0;2020; 81:e4&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. &#xa0;Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March&#x2013;June 2020. Morbid Mortal Week Rep &#xa0;2020; 69:993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, et al. &#xa0;Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA &#xa0;2020; 324:782&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72&#x202f;314 cases from the Chinese Center for Disease Control and Prevention. JAMA &#xa0;2020; 323:1239&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, et al. &#xa0;Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus&#x2013;infected pneumonia in Wuhan, China. JAMA &#xa0;2020; 323:1061&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X, Jian W, Su Z, et al. &#xa0;Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Resp J &#xa0;2020; 55:2001217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli A, Misuraca C, Bianchi A, et al. &#xa0;Pulmonary function in patients surviving to COVID-19 pneumonia [published online ahead of print July 28, 2020]. Infection &#xa0;2020; doi:10.1007/s15010-020-01474-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01474-9</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et al. &#xa0;Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol &#xa0;2020; 5:1265&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Kruip MJ, Van der Meer NJ, et al. &#xa0;Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis Res &#xa0;2020; 191:145&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146714</ArticleId><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Patell R, Bogue T, Koshy AG, et al. &#xa0;Post-discharge thrombosis and hemorrhage in patients with COVID-19. Blood &#xa0;2020; 136:1342&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483433</ArticleId><ArticleId IdType="pubmed">32766883</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S, Kearon C; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost &#xa0;2005; 3:692&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">15842354</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Leizorovicz A, Kakkar AK, et al. ; ADOPT Trial Investigators Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med &#xa0;2011; 365:2167&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">22077144</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson CM, Halaby R, Korjian S, et al. ; APEX Investigators The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial. Am Heart J &#xa0;2017; 185:93&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">28267480</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelen MM, Vanassche T, Balthazar T, et al. &#xa0;Incidence of venous thromboembolism in patients discharged after COVID-19 hospitalisation [abstract]. Res Pract Thromb Haemost &#xa0;2020; 4(Suppl 1).</Citation></Reference><Reference><Citation>Roberts LN, Whyte MB, Georgiou L, et al. &#xa0;Post-discharge venous thromboembolism following hospital admission with COVID-19. Blood &#xa0;2020; 136:1347&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483432</ArticleId><ArticleId IdType="pubmed">32746455</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Xu X, Chen Z, et al. &#xa0;Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun &#xa0;2020; 87:18&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A, Masciocchi S, Volonghi I, et al. &#xa0;ENCOVID Study Group, clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study [published online ahead of print September 28, 2020]. J Infect Dis &#xa0;2020; doi:10.1093/infdis/jiaa609</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa609</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch JS, Ng JH, Ross DW, et al. ; Northwell COVID-19 Research Consortium; Northwell Nephrology COVID-19 Research Consortium Acute kidney injury in patients hospitalized with COVID-19. Kidney Int &#xa0;2020; 98:209&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7229463</ArticleId><ArticleId IdType="pubmed">32416116</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L, Chaudhary K, Saha A, et al. &#xa0;AKI in hospitalized patients with COVID-19 [published online ahead of print September 3, 2020]. J Am Soc Nephrol &#xa0;2020; doi:10.1681/ASN.2020050615</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020050615</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng JH, Hirsch JS, Hazzan A, et al. &#xa0;Outcomes among patients hospitalized with COVID-19 and acute kidney injury [published online ahead of print September 19, 2020]. Am J Kidney Dis &#xa0;2020; doi:10.1053/j.ajkd.2020.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2020.09.002</ArticleId><ArticleId IdType="pmc">PMC7833189</ArticleId><ArticleId IdType="pubmed">32961245</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucaloiu ID, Kirchner HL, Norfolk ER, et al. &#xa0;Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int &#xa0;2012; 81:477&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">22157656</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker-Davies RM, O&#x2019;Sullivan O, Senaratne KPP, et al. &#xa0;The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med &#xa0;2020; 54:949&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418628</ArticleId><ArticleId IdType="pubmed">32475821</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufort EM, Koumans EH, Chow EJ, et al. ; New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team Multisystem inflammatory syndrome in children in New York State. N Engl J Med &#xa0;2020; 383:347&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7346766</ArticleId><ArticleId IdType="pubmed">32598830</ArticleId></ArticleIdList></Reference><Reference><Citation>Riphagen S, Gomez X, Gonzalez-Martinez C, et al. &#xa0;Hyperinflammatory shock in children during COVID-19 pandemic. Lancet &#xa0;2020; 395:1607&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204765</ArticleId><ArticleId IdType="pubmed">32386565</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E, Bamford A, Kenny J, et al. &#xa0;Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA &#xa0;2020; 324:259&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdoni L, Mazza A, Gervasoni A, et al. &#xa0;An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet &#xa0;2020; 395:1771&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220177</ArticleId><ArticleId IdType="pubmed">32410760</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Rose EB, Horwitz SM, et al. &#xa0;Multisystem inflammatory syndrome in US children and adolescents. N Eng J Med &#xa0;2020; 383:334&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention. Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C) Available at: https://www.cdc.gov/mis-c/hcp/. Accessed 31 August 2020.</Citation></Reference><Reference><Citation>Godfred-Cato S, Bryant B, Leung J, et al. &#xa0;COVID-19&#x2013;associated multisystem inflammatory syndrome in children&#x2014;United States, March&#x2013;July 2020. Morbid Mortal Week Rep &#xa0;2020; 69:1074&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7440126</ArticleId><ArticleId IdType="pubmed">32790663</ArticleId></ArticleIdList></Reference><Reference><Citation>Bamrah Morris S, Schwartz N, Patel P, et al. &#xa0;Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection - United Kingdom and United States, March-August 2020. Morbid Mortal Week Rep &#xa0;2020; 69:1450&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7561225</ArticleId><ArticleId IdType="pubmed">33031361</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue Biomed Health Behav &#xa0;2020; 8:61&#x2013;9.</Citation></Reference><Reference><Citation>Tansey CM, Louie M, Loeb M, et al. &#xa0;One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med &#xa0;2007; 167:1312&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">17592106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH, Wing YK, Yu MW, et al. &#xa0;Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med &#xa0;2009; 169:2142&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>
Institute of Medicine (US), Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome -- Redefining an illness: Report guide for clinicians. 2005. Available at: https://www.nap.edu/resource/19012/MECFScliniciansguide.pdf</Citation></Reference><Reference><Citation>Ahmed H, Patel K, Greenwood DC, et al. &#xa0;Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J Rehab Med &#xa0;2020; 52:jrm00063.</Citation><ArticleIdList><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE, Heo JH, Kim HO, et al. &#xa0;Neurological complications during treatment of Middle East respiratory syndrome. J Clin Neurol &#xa0;2017; 13:227&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5532318</ArticleId><ArticleId IdType="pubmed">28748673</ArticleId></ArticleIdList></Reference><Reference><Citation>Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun &#xa0;2020; 87:34&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7152874</ArticleId><ArticleId IdType="pubmed">32298803</ArticleId></ArticleIdList></Reference><Reference><Citation>Broderick G, Fuite J, Kreitz A, et al. &#xa0;A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun &#xa0;2010; 24:1209&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2939140</ArticleId><ArticleId IdType="pubmed">20447453</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden S, Kueknel M, et al. &#xa0;Pulmonary vascular endothlialitis, thombosis, and angiogenesis in Coivd-19. NEJM &#xa0;2020; 383:120&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham DM, Davidson J, Cohen H, et al. &#xa0;Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders&#x2019; conference. Crit Care Med &#xa0;2012; 40:502&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21946660</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>